Home › Vision Impairment and Blindness › Massachusetts
Vision Impairment and Blindness clinical trials in Massachusetts
4 studies for Vision Impairment and Blindness are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
- Massachusetts Eye and Ear, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT05844982OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
- Northeast Eye Research Associates, Woburn
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07140783Valproate for the Treatment of Residual Amblyopia
- Boston Children's Hospital, Boston
RecruitingPhase 1/2
Ages 8 to 17 · All sexes · Updated Jul 30, 2026 · NCT07226141Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates
- Brigham and Women's Hospital, and Boston Children's Hospital, Boston
RecruitingObservational study
31 Weeks – 42 Weeks · All sexes · Updated Dec 10, 2025 · NCT07275021From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.